Superficial Cervical Plexus Block for Pacemaker Insertion

Pain Clinical Trial

Official title:

Superficial Cervical Plexus Block for Pacemaker Insertion

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01473667
• Other study ID #: 11-005969
• Status: Terminated
• Phase: N/A
• Start date: November 2011
• Est. completion date: September 2016

Study information

• Verified date: January 2019
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate clinical outcomes from two current standard of care pain control procedures performed for patients undergoing pacemaker insertion.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 30
• Est. completion date: September 2016
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Age 18-100 years old

• Registered patients at Mayo Clinic in Florida scheduled to undergo primary insertion of pacemaker

Exclusion Criteria:

• Emergency placement of pacemaker

• Sub-pectoral placement of pacemaker

• Patients with history of chronic pain

• Patients with anatomical abnormality or disruption to the pacemaker insertion site or site of block placement

• Patients with allergy to local anesthetic

Related Conditions & MeSH terms

• Pacemaker Insertion
• Pain
• Regional Block

Intervention

Procedure:
• Superficial Cervical Plexus Block (SCP) block
SCP block using 10-15ml of 1% Ropivacaine
• Local site infiltration
Local site infiltration using 2% lidocaine

Locations

Country	Name	City	State
United States	Mayo Clinic	Jacksonville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To decrease opioid requirements after Pacemaker insertion		first 24 hrs post pacemaker insertion